Innovex International, Inc. — Earnings Quality Grade A
INVX · Energy
Strong financial health
Screening Summary
Management Signals
Source: SEC EDGAR 8-K Item 5.02, with exhibit links when available
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 86 days, change -66 days YoY
AR growth -16.5% vs revenue growth 48.0%
Revenue 48.0%, CFFO 104.3%. Cash follows revenue
Expense Quality
Inventory -8.4% vs COGS 57.6%. Normal
CapEx growth 158.4% is >2x revenue growth 48.0%
SG&A/Gross Profit = 42.5%. Normal
Gross margin 31.0%, change -4.2pp. Stable
Cash Flow Quality
CFFO/NI = 2.29. Profits backed by cash
FCF $0.2B, FCF/NI = 1.87
Accruals ratio = -8.5%. Low accruals
Cash $0.2B covers debt $0.1B
Balance Sheet Health
Goodwill+Intangibles $0.2B = 20% of equity. Manageable
Debt/EBITDA = 0.4x. Healthy
Other assets 47.6% vs revenue 48.0%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change 28% YoY. Normal
Manipulation Score
M-Score = -2.71 (< -2.22). Unlikely manipulator
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25